INFORECERCA: Butlletí Informatiu del Servei de Recerca de l'IMIM
Número: 567
20/07/2018
Comentaris i suggeriments
Banner-noves-convocatories-02
Cercador de convocatòries
Projectes
Termini exhaurit
INNOVATIVE MEDICINES INITIATIVE
IMI is a partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA).
The goal of the Innovative Medicines Initiative 2 (IMI 2) is to develop next generation vaccines, medicines and treatments, such as new antibiotics. It will build on the successes and lessons learnt under IMI. Like IMI, it will bring together companies, universities, public laboratories, innovative small and medium-sized enterprises (SMEs), patient groups and regulators in collaborative projects that will pave the way for breakthrough vaccines, medicines and treatments to tackle Europe’s growing health challenges, and secure the future international competitiveness of Europe’s pharmaceutical industry.
 
Termini exhaurit
INNOVATIVE MEDICINES INITIATIVE
IMI is a partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA).
The goal of the Innovative Medicines Initiative 2 (IMI 2) is to develop next generation vaccines, medicines and treatments, such as new antibiotics. It will build on the successes and lessons learnt under IMI. Like IMI, it will bring together companies, universities, public laboratories, innovative small and medium-sized enterprises (SMEs), patient groups and regulators in collaborative projects that will pave the way for breakthrough vaccines, medicines and treatments to tackle Europe’s growing health challenges, and secure the future international competitiveness of Europe’s pharmaceutical industry.
 
Termini exhaurit
ALZHEIMER'S DRUG DISCOVERY FOUNDATION
Bill Gates and ADDF co-founder Leonard Lauder are partnering and adopting a new approach that brings together philanthropic capital with a venture mindset to advance bold new ideas for easier and more accurate diagnosis of Alzheimer's disease and related dementias.
 
Borses de viatge
Termini exhaurit
EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER
The European Association for the Study of the Liver is a major European Association with international influence dedicated to the liver and liver disease. EASL has over 4,000 members from all over the world and provides an annual platform, The International Liver Congress™, for 11,000 liver experts to meet and discuss latest scientific research.

The Short-Term Fellowship programme is directed at postgraduate investigators (both basic and clinical investigators) who intend to spend a limited amount of time (usually 3-6 months) at a foreign institution to accomplish a very focused research project, to learn an experimental procedure or methodology, or to get in-depth knowledge about a sophisticated, clinical diagnostic procedure not available at the Home Institution.
 
Termini exhaurit
EUROPEAN FOUNDATION FOR THE STUDY OF DIABETES (EFSD)
The Albert Renold Travel Fellowships for Young Scientists will enable young scientists to travel to and to stay at other institutions in another country in order to learn different scientific techniques related to diabetes research.
 
Premis
Termini exhaurit
MSCBS - MINISTERIO DE SANIDAD
Es poden presentar projectes que tinguin entre els seus objectius bàsics la prevenció de l’obesitat i d’altres malalties cròniques derivades, que fomentin l’alimentació saludable i la pràctica regular d’activitat física i que es desenvolupin en el marc dels objectius de l’Estratègia NAOS.
 
Termini exhaurit
FPdGI - FUNDACIÓ PRINCESA DE GIRONA
Dirigida a premiar la trajectòria de joves científics (Inclosos els que treballen en el camp de les ciències humanes i socials) amb experiències o projectes d'investigació destacats en la seva disciplina, emprenedors, innovadors i amb un elevat potencial de desenvolupament futur.
 
Termini exhaurit
HOSPITAL SAN RAFAEL DE LA CORUÑA
La vinticinquena edició del premi Rafael Hervada estarà dedicat a la cirurgia avançada en el càncer de pulmó. Aquest premi està dedicat no només a les tècniques quirúrgiques sinó també a totes aquelles terapèutiques que siguin coadjuvants, com pot ser la radioteràpia o la immunoteràpia. Pretenem amb la convocatòria d'aquest Premi el reconeixement a la innovació i a l'eficàcia en el tractament del càncer de pulmó, realitzant així una petita contribució al coneixement i a la investigació en aquesta patologia tumoral.
 
Recursos Humans
Termini exhaurit
FEHH - FUNDACION ESPAÑOLA DE HEMATOLOGIA Y HEMOTERAPIA
Convocar un programa de 10 beques per gaudir l'any 2019: 7 de la FEHH i 2 d'una col·laboració FEHH/Janssen. Les beques van dirigides a socis de la Societat Espanyola d'Hematologia i Hemoteràpia que vulguin realitzar un projecte d'investigació en un centre espanyol, en l'àmbit de les àrees que conformen l'especialitat d'Hematologia i Hemoteràpia.
Seguint l'esperit integrador de la FEHH, cada any una de les beques estarà destinada prioritàriament a alguna àrea concreta de l'hematologia. A la present convocatòria s'ha designat per una de les 9 beques l'àrea d'Hematologia clínica. A més, les 2 beques de col·laboració FEHH/Janssen quedaran circumscrites l'àrea d'hemopaties malignes, donant prioritat a mieloma múltiple i síndromes limfoproliferatives cròniques.
 
 
 
Informació últil
 
 No hi ha novetats
 
 
Banner-convocatories-tancament-02
Projectes
Termini exhaurit
FUNDACIÓN DE INVESTIGACIÓN ONCOLÓGICA (FERO)
La finalitat de la beca és completar la formació de joves investigadors en el camp de l'Oncologia i promoure la ràpida transmissió dels avenços científics en aquest camp als pacients. Per això, es reconeix un projecte científic presentat per professionals novells que treballin en institucions espanyoles involucrades en aquest tipus d'investigació. En aquesta convocatòria i de manera excepcional, tenim a més un Beca extraordinària en càncer de mama, per promoure a joves investigadors a treballar en el camp del càncer de mama.
L'acte de lliurament de la 15a edició de la Beca FERO tindrà lloc el 3 de desembre de 2018 a Madrid.
El premiat haurà d'estar present en la cerimònia de lliurament de la beca.
 
Termini exhaurit
FJL - FONDATION JEROME LEJEUNE
The main target of the Fondation Jerome Lejeune, a non profit foundation, is research into genetic diseases with intellectual disability.
 
Termini exhaurit
DEPARTMENT OF DEFENSE
The mission of the FY18 PCRP is to fund research that will lead to the elimination of death from prostate cancer and enhance the well-being of Service members, Veterans, and all men experiencing the impact of the disease. Within this context, the PCRP is interested in supporting research that addresses specific gaps in prostate cancer research and clinical care. Therefore, applications are required to address one or more of the following FY18 PCRP Overarching Challenges:
  • Develop treatments that improve outcomes for men with lethal prostate cancer
  • Reduce lethal prostate cancer in African Americans, Veterans, and other high-risk populations
  • Define the biology of lethal prostate cancer to reduce death
  • Improve the quality of life for survivors of prostate cancer
    		•
     
    Altres
    Termini exhaurit
    EFIS - EUROPEAN FEDERATION OF IMMUNOLOGICAL SOCIETIES
    EFIS and the European Journal of Immunology (EJI) are proud to offer financial support for immunology-themed meetings, workshops and schools that are organized in Europe and are international in nature.

    Specifically, through its support, EFIS aims to enhance interaction between young scientists and established immunologists, providing funding to be used as travel bursaries to award to eligible and deserving junior researchers who, in many cases, would be unable to attend quality immunology-themed events without such support.
     
    Termini exhaurit
    EFIS - EUROPEAN FEDERATION OF IMMUNOLOGICAL SOCIETIES
    To stimulate and facilitate interaction among European researchers working in specific fields of immunology, thereby helping to create European platforms on a topic-oriented, bottom-up level, EFIS – in collaboration with its Official Journal Immunology Letters (IL) – invites proposals for the establishment of EFIS-IL Study Groups on specific areas of immunology-related research.
     
    Premis
    Termini exhaurit
    AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR)
    The AACR-CRI Lloyd J. Old Award in Cancer Immunology was established to honor the memory of the late Lloyd J. Old and will recognize an active scientist whose outstanding and innovative research in cancer immunology has had a far-reaching impact on the cancer field.
     
    Recursos Humans
    Termini exhaurit
    EMBO - THE EUROPEAN MOLECULAR BIOLOGY ORGANIZATION
    The EMBO Long-Term Fellowships support post-doctoral research visits to laboratories throughout Europe and the world. International exchange is a key feature in the application process.
     
    Termini exhaurit
    HUMAN FRONTIER SCIENCE PROGRAMME
    HFSP postdoctoral fellowships encourage early career scientists to broaden their research skills by moving into new areas of study while working in a new country. The HFSP fellowship program strongly supports frontier, potentially transformative (‘out-of-the-box’) proposals and encourages applications for high-risk projects

    HFSP fellowships are for three years. Fellows may choose to stay for up to three years in the host country or use the last year of their fellowship to return to their home country or to move to another HFSPO member country.

    Long-Term Fellowships (LTF) are for applicants with a Ph.D. in a biological discipline, who will broaden their expertise by proposing a project in the life sciences which is significantly different from their previous Ph.D. or postdoctoral work.

    Cross-Disciplinary Fellowships (CDF) are for applicants with a Ph.D. from outside the life sciences (e.g. in physics, chemistry, mathematics, engineering or computer sciences), who have not worked in biological fields before.
     
     
     
     
    Articles
     
    Gelber PE*, Perelli S, Ibañez M, Ramírez-Bermejo E, Fariñas O, Monllau JC, Sanchis-Alfonso V. Fresh Osteochondral Patellar Allograft Resurfacing. Arthrosc Tech 2018; 7(6): e617-e622.
     
    Gelber PE*, Erquicia JI, Ramírez-Bermejo E, Fariñas O, Monllau JC. Fresh Osteochondral and Meniscus Allografting for Post-traumatic Tibial Plateau Defects. Arthrosc Tech 2018; 7(6): e661-e667.
     
    de Prado P, Mercader EMH, Pujol J, Sunyer J, Mortamais M*. The Effects of Air Pollution on the Brain: a Review of Studies Interfacing Environmental Epidemiology and Neuroimaging. Curr Environ Health Rep 2018; 5(3): 351-364.
     
    De Backer, Monlezun S, Detraux B, Gazan A, Vanopdenbosch L, Cheron J, Cannazza G, Valverde S, Cantacorps L, Nassar M, Venance L, Valverde O, Faure P, Zoli M, De Backer O, Gall D, Schiffmann SN, de Kerchove d'Exaerde A*. Deletion of Maged1 in mice abolishes locomotor and reinforcing effects of cocaine. Embo Rep 2018; 19(9): e45089.
     
    Bigas A*, Espinosa L*. The multiple usages of Notch signaling in development, cell differentiation and cancer. Curr Opin Cell Biol 2018; 55: 1-7.
     
    Bisschops R, Manning J, Clayton LB, Ng Kwet Shing R, Alvarez-González MA, MORA Study Group. Colon cleansing efficacy and safety with 1 L NER1006 versus 2 L polyethylene glycol + ascorbate: a randomized phase 3 trial. Endoscopy 2019; 51(1): 60-72.
     
    Pizzagalli DU, Farsakoglu Y, Palomino-Segura M, Palladino E, Sintes J, Marangoni F, Mempel TR, Koh WH, Murooka TT, Thelen F, Stein JV, Pozzi G, Thelen M, Krause R*, Gonzalez SF*. Leukocyte Tracking Database, a collection of immune cell tracks from intravital 2-photon microscopy videos. Sci Data 2018; 5: 180129.
     
    Sonpavde GP, Mariani L, Lo Vullo S, Raggi D, Giannatempo P, Bamias A, Crabb SJ, Bellmunt J, Yu EY, Niegisch G, Vaishampayan UN, Theodore C, Berthold DR, Srinivas S, Sridhar SS, Plimack ER, Rosenberg JE, Powles T, Galsky MD, Necchi A. Impact of the number of cycles of platinum-based first-line chemotherapy for advanced urothelial carcinoma. J Urol 2018; 200(6): 1207-1214.
     
    Kogevinas M*, Espinosa A, Castelló A, Gómez Acebo I, Guevara M, Martin V, Amiano P, Alguacil J, Peiro R, Moreno V, Costas Caudet L, Fernández Tardón G, Jimenez JJ, Marcos-Gragera R, Perez-Gomez B, Llorca J, Moreno-Iribas C, Fernández-Villa T, Oribe M, Aragones N, Papantoniou K, Pollán M, Castaño Vinyals G, Romaguera D. Effect of mistimed eating patterns on breast and prostate cancer risk (MCC-Spain Study). Int J Cancer 2018; 143(10): 2380-2389.
     
    de Jesús-Gil C, Ruiz-Romeu E, Ferran M, Chiriac A, Deza G, Hóllo P, Celada A, Pujol RM, Santamaria-Babí LF*. CLA+ T Cell Response to Microbes in Psoriasis. Front Immunol 2018; 9: 1488.
     
    Verdolini N, Pacchiarotti I, Köhler CA, Reinares M, Samalin L, Colom F, Tortorella A, Stubbs B, Carvalho AF, Vieta E*, Murru A. Violent criminal behavior in the context of bipolar disorder: Systematic review and meta-analysis. J Affect Disorders 2018; 239: 161-170.
     
     
    Leyva-Moral JM, Feijoo-Cid M*, Moriña D, Caylà JA, Arando M, Vall M, Barbera MJ, Armengol P, Vives A, Martín-Ezquerra G, Alsina M, García-Olalla P. Gay Circuit Parties in Barcelona and Their Impact on Gonorrhea Incidence. Arch Sex Behav 2018; 47(7): 2027-2034.
     
    Waage J, Standl M, Curtin JA, Jessen LE, Thorsen J, Tian C, Schoettler N, Flores C, Abdellaoui A, Ahluwalia TS, Alves AC, Amaral AFS, Antó JM, Arnold A, Barreto-Luis A, Baurecht H, van Beijsterveldt CE, Bleecker ER, Bonàs-Guarch S, Boomsma DI, Brix S, Bunyavanich S, Burchard EG, Chen Z, Curjuric I, Custovic A, den Dekker HT, Dharmage SC, Dmitrieva J, Duijts L, Ege MJ, Gauderman WJ, Georges M, Gieger C, Gilliland F, Granell R, Gui H, Hansen T, Heinrich J, Henderson J, Hernandez-Pacheco N, Holt P, Imboden M, Jaddoe VWV, Jarvelin MR, Jarvis DL, Jensen KK, Jónsdóttir I, Kabesch M, Kaprio J, Kumar A, Lee YA, Levin AM, Li X, Lorenzo-Diaz F, Melén E, Mercader JM, Meyers DA, Myers R, Nicolae DL, Nohr EA, Palviainen T, Paternoster L, Pennell CE, Pershagen G, Pino-Yanes M, Probst-Hensch NM, Rüschendorf F, Simpson A, Stefansson K, Sunyer J, Sveinbjornsson G, Thiering E, Thompson PJ, Torrent M, Torrents D, Tung JY, Wang CA, Weidinger S, Weiss S, Willemsen G, Williams LK, Ober C, Hinds DA, Ferreira MA, Bisgaard H, Strachan DP, Bønnelykke K*, AAGC collaborators. Genome-wide association and HLA fine-mapping studies identify risk loci and genetic pathways underlying allergic rhinitis. Nat Genet 2018; 50(8): 1072-1080.
     
    Procopet B, Giráldez Á, Amitrano L, Villanueva C, Thabut D, Ibañez-Samaniego L, Silva-Junior G, Martinez-Lainez JM, Genescà J, Bureau C, Trebicka J, Llop E, Laleman W, Palazon JM, Castellote J, Rodrigues S, Gluud LL, Noronha Ferreira, Barcelo R, Cañete N, Rodríguez M, Ferlitsch A, Mundi JL, Gronbaek H, Hernández-Guerra M, Sassatelli R, Dell'Era A, Senzolo M, Gonzalez-Abraldes J, Romero-Gómez M, Zipprich A, Casas M, Masnou H, Primignani M, Krag A, Nevens F, Calleja JL, Jansen C, Robic MA, Conejo I, Catalina MV, Albillos A, Rudler M, Alvarado E, Guardascione MA, Tantau M, Bosch J, Torres F, Garcia-Pagán JC*, International Variceal Bleeding Observational Study Group and Baveno Cooperation. Preemptive-TIPS improves outcome in high-risk variceal bleeding: An observational study. Hepatology 2019; 69(1): 282-293.
     
     
    Institut Hospital del Mar d'Investigacions Mèdiques
    Tel: 93 316 04 00
    Doctor Aiguader, 88
    08003 Barcelona
    Seguiu-nos a:
    Twitter
    Youtube
    En compliment de la Llei 34/2002, de Serveis de la Societat de la Informació i de Comerç Electrònic, aquest correu li hem enviat a partir de les dades de contacte que vostè ens ha facilitat. Si vostè no desitja rebre més comunicats, pot donar-se de baixa dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es) tot indicant la paraula “baixa base de dades” a l’assumpte.
    Li recordem que podrà exercir els drets d’accés, rectificació, cancel·lació i oposició dirigint-se per escrit al Servei de Recursos Humans-IMIM (RRHHconfidencialitat@imim.es).